Triple
T2523541
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | CB1 receptor |
E55578
|
entity |
| Predicate | antagonist |
P4675
|
FINISHED |
| Object |
rimonabant
Rimonabant is a selective cannabinoid CB1 receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
|
E275982
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: rimonabant | Statement: [CB1 receptor, antagonist, rimonabant]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: rimonabant Context triple: [CB1 receptor, antagonist, rimonabant]
-
A.
CB1 receptor
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
-
B.
Sabu
Sabu is an alternative name for the Shabo language, a little-documented and possibly language-isolate tongue spoken by a small community in southwestern Ethiopia.
-
C.
Substiane
Substiane is a La Roche-Posay skincare line formulated to address loss of firmness, density, and comfort in mature or aging skin.
-
D.
THC
THC (tetrahydrocannabinol) is the primary psychoactive compound in cannabis responsible for the plant’s mind-altering effects.
-
E.
Acubens
Acubens is the traditional name of Alpha Cancri, a multiple star system in the constellation Cancer.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: rimonabant Triple: [CB1 receptor, antagonist, rimonabant]
Generated description
Rimonabant is a selective cannabinoid CB1 receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: rimonabant Target entity description: Rimonabant is a selective cannabinoid CB1 receptor antagonist that was developed as an anti-obesity drug but withdrawn due to psychiatric side effects.
-
A.
CB1 receptor
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
-
B.
Sabu
Sabu is an alternative name for the Shabo language, a little-documented and possibly language-isolate tongue spoken by a small community in southwestern Ethiopia.
-
C.
Substiane
Substiane is a La Roche-Posay skincare line formulated to address loss of firmness, density, and comfort in mature or aging skin.
-
D.
THC
THC (tetrahydrocannabinol) is the primary psychoactive compound in cannabis responsible for the plant’s mind-altering effects.
-
E.
Acubens
Acubens is the traditional name of Alpha Cancri, a multiple star system in the constellation Cancer.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ab49e4749c8190813311efd1630f1b |
completed | March 6, 2026, 9:40 p.m. |
| NER | Named-entity recognition | batch_69abd23a0a548190b44393e0f823f7a9 |
completed | March 7, 2026, 7:22 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69af2ba96a0c819091efd6d4ccf95ea5 |
completed | March 9, 2026, 8:20 p.m. |
| NEDg | Description generation | batch_69af508c28f48190afc4aa1bc3c9adf3 |
completed | March 9, 2026, 10:58 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69af5155f85081908dd4a1859d0f7907 |
completed | March 9, 2026, 11:01 p.m. |
Created at: March 6, 2026, 9:46 p.m.